Chromadex Corp CS (CDXC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
7.87 -0.07 (-0.88%) 03/18/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 7.87 unch (unch) -
for Tue, Mar 18th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CDXC | ARVN | NAGE | ||
| Company | Chromadex Corp CS | Arvinas Inc | Niagen Bioscience Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.91 | 9.31 | 7.57 | ||
| High | 7.92 | 9.55 | 7.83 | ||
| Low | 7.75 | 9.11 | 7.53 | ||
| Last | 7.87 | 9.37 | 7.78 | ||
| Change | -0.07 | +0.16 | +0.16 | ||
| % Change | -0.88% | +1.74% | +2.10% | ||
| Volume | 554,800 | 1,700,700 | 370,900 | ||
| 20-Day Average Volume | 1,676,165 | 2,425,485 | 621,595 | ||
| Previous Close | 7.94 | 9.21 | 7.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.73 | 7.76 | 6.59 | ||
| 20-Day Raw Stochastic | 66.67% | 95.03% | 98.00% | ||
| 20-Day Relative Strength | 64.91% | 47.10% | 60.82% | ||
| Weighted Alpha | +49.26 | -48.69 | +38.56 | ||
| Today's Opinion | 96% Buy | 88% Sell | 88% Buy | ||
| Previous Opinion | 96% Buy | 88% Sell | 88% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.38% since 03/11/25 | +4.81% since 04/22/25 | +12.92% since 04/22/25 | ||
| Low | 7.32 on 03/13/25 | 8.83 on 04/23/25 | 7.12 on 04/24/25 | ||
| High | 8.00 on 03/17/25 | 9.55 on 04/29/25 | 7.83 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | +33.16% since 02/18/25 | +23.45% since 03/28/25 | +14.92% since 03/28/25 | ||
| Low | 5.25 on 02/24/25 | 5.93 on 04/09/25 | 5.33 on 04/09/25 | ||
| High | 9.18 on 03/05/25 | 9.55 on 04/29/25 | 7.83 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | +38.07% since 12/18/24 | -46.61% since 01/29/25 | +31.86% since 01/29/25 | ||
| Low | 5.16 on 01/07/25 | 5.93 on 04/09/25 | 5.25 on 02/24/25 | ||
| High | 9.18 on 03/05/25 | 20.38 on 02/18/25 | 9.18 on 03/05/25 | ||
| 6-Month | |||||
| %Chg | +121.69% since 09/18/24 | -65.93% since 10/29/24 | +114.92% since 10/29/24 | ||
| Low | 3.18 on 10/10/24 | 5.93 on 04/09/25 | 3.49 on 10/31/24 | ||
| High | 9.18 on 03/05/25 | 29.61 on 10/30/24 | 9.18 on 03/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 611,893 | 633,390 | 592,455 | ||
| Shares Outstanding, K | 77,750 | 68,772 | 77,750 | ||
| Annual Sales | 99,600,000 | 263,400,000 | 99,600,000 | ||
| Annual Net Income | 8,550,000 | -198,900,000 | 8,550,000 | ||
| Last Quarter Sales | 29,130,000 | 59,200,000 | 29,130,000 | ||
| Last Quarter Net Income | 7,180,000 | -45,100,000 | 7,180,000 | ||
| 60-Month Beta | 2.21 | 2.30 | 2.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.03 on 03/04/25 | -0.63 on 02/11/25 | 0.03 on 03/04/25 | ||
| Latest Earnings Date | 03/04/25 | 05/01/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 198.50 | 0.00 | 184.50 | ||